Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

WCLC 2024

Lung, Respiratory and Thoracic Cancer

TROPION-Lung01: Quantitative Continuous Scoring of TROP2 Normalized Membrane Ratio Predicts Clinical Outcomes in Patients With NSCLC

Lung, Respiratory and Thoracic Cancer

Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition

Lung Cancer

Saal J, Bald T, Eckstein M, Ralser DJ, Brossart P, Ellinger J, Hölzel M, Klümper N

doi: 10.1016/j.lungcan.2024.107505

Further Publications

Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data

J Clin Oncol

Nguyen NH, Dodd-Eaton EB, Corredor JL, Woodman-Ross J, Green S, Gutierrez AM, Arun BK, Wang W

doi: 10.1200/JCO.23.01926

Leukemia

Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers

Am J Hematol

Abaza Y, Winer ES, Murthy GSG, Shallis RM, Matthews AH, Badar T, Geramita EM, Kota VK, Swaroop A, Doukas P, Bradshaw D, Helenowski IB, Liu Y, Zhang H, Im A, Litzow MR, Perl AE, Atallah E, Altman JK

doi: 10.1002/ajh.27231

EHA 2024

Leukemia

Insights into clinical outcomes of patients with R/R AML after treatment with gilteritinib

SABCS 2024

Breast Cancer

Advancing Breast Cancer Treatment with Elacestrant

Further Publications

Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing Data

Cancer Discov

Darmofal M, Suman S, Atwal G, Toomey M, Chen JF, Chang JC, Vakiani E, Varghese AM, Balakrishnan Rema A, Syed A, Schultz N, Berger MF, Morris Q

doi: 10.1158/2159-8290.CD-23-0996

ASCO 2024

Genitourinary Cancer

PSMAfore: ¹⁷⁷Lu-PSMA-617 improves clinical outcomes versus ARPI change irrespective of baseline ctDNA fraction or the presence of negative prognostic biomarkers

Multiple Myeloma (MM)

Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries

Eur J Cancer

Abildgaard N, Anttila P, Waage A, Rubin KH, Ørstavik S, Bent-Ennakhil N, Gavini F, Ma Y, Freilich J, Hansson M

doi: 10.1016/j.ejca.2024.113921

Related content